Decibel Cannabis Company has closed a transaction to acquire AgMedica Bioscience pursuant to an assignment agreement dated October 28, 2024 entered into with Callisto Capital Corp in exchange for a $6.3 million unsecured convertible debenture.
Benjamin Sze, CEO said: "I am excited to announce the acquisition of AgMedica. A euGMP certification is an international standard that Decibel has been contemplating for quite some time, this acquisition accelerates that timeline."
For more information:
Decibel Cannabis Company
[email protected]
decibelcc.com